For instance, the use of multiparametric-MRI targeted prostate biopsy in combination with PHI and PSA isoforms, has been shown to improve PCa risk stratification as compared with urinary biomarkers or PSA alone [22]. The gene discussed is KLK3; the disease is posterior cortical atrophy.